All News

The recent FDA approval of Biogen’s controversial drug aducanumab is the first drug approved for Alzheimer’s disease in nearly 20 years, and highlights the urgent need for new disease modifying approaches in drug development in this indication.

Janssen has launched series of videos and written perspectives on The Mighty, an online patient network, to highlight the stories of individuals living with pulmonary arterial hypertension (PAH).

It's time to apply the same COVID-19 urgency to other devastating diseases, such as Alzheimer’s, write Andrea Pfeifer and William Mobley.

NURTEC ODT approved for the preventive treatment of adult patients who experience less than 15 headache days per month.

The European Commission’s Genetically Modified Organism (GMO) legislation hurts Europe’s ability to attract clinical trials and delays patient access to transformative medicines, say European industry associations.

Becton, Dickinson and Company is to build a $200 million high-tech manufacturing facility in Zaragoza, Spain.

Deloitte acquires Iperion Life Sciences, which will now run as part of Deloitte’s Risk Advisory function.

Forecast excludes spending on COVID-19 vaccines, according to IQVIA Institute for Human Data Science study.

Specialized Intensive Learning Academies (ILAs) "will deliver transformational training and support across preventative health, value-based health and care, and innovations in health and social care."

Ethics and diversity on full display across pharma industry.

A picture of wide manufacturing violations appears in a recently disclosed FDA form 483 report on a site visit to Emergent’s Baltimore vaccine plant.

Next tier of markets is poised to ascend and offer valuable opportunities to both investors and occupiers.

Healthcare providers across Canada will be able to capture adverse events in the Auxita platform through integration with MyMeds&Me’s pharmacovigilance SaaS platform, Reportum.

This month brings the IR35 tax reform on the UK’s private sector. How will it affect the pharma industry?

Report provides comprehensive look at financial and accounting issues faced by life sciences industry.

Federal Trade Commission to launch a broad review of drug-company mergers.

New initiative from late-stage research and patient-support services organization aims to accelerate COVID-19 vaccine development.

MassBio’s latest Biopharma Funding Report shows Massachusetts biopharma companies raised record-breaking $5.8 billion in VC Funding in 2020.

FDA accepted Impel’s new drug application (NDA) for TRUDHESA last month.

Not to be outdone by the showbiz industry, Pharm Exec's own awards season is fast approaching.

Report highlights how lung cancer progress in diagnosis has been pushed back, with further impact on treatment likely as the pandemic continues.

Week-long event aims to help commercialize innovations to reach patients in need.

Embracing the new, holistic views of pharma in 2021.

Panel will provide guidance around evolving digital business models.

Lead company is seeking others to join the initiative.

Mike Hennessey Sr., Chairman and Founder of MJH Life Sciences, pushes for the celebration of the pharmaceutical industry after nine grueling months of fighting COVID-19.

Prescription opioid Use in the U.S. has declined by 60% from 2011 Peak, according to new report from IQVIA.